Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

+6.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Walster who wrote (607)	11/3/1997 12:33:00 PM
From: Giuseppe Scalamogna	of 1605

Don, In here the company can very well sustain their recent run if positive news justifies this valuation. Rememeber, prices move in anticipation of things and I personally think we will move higher as results from the conference will lend greater visibility into the companies financial well-being going forward. EECP for all intents and purposes is still being "tested" by physicians and hasn't become mainstream treatment yet. That is why the results of MUST-EECP will be so important. If positive more physicians will accept the technology and sales could increase at least five-fold. Couple this with 100% medicaire reimbursement and you have a great non-invasise, outpatient cost-effective system to treat Angina Pectoris. Skepticism still looms and some of the fog will be cleared November 11. Things look positive to me, GS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next